Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Grosshansdorf

69 clinical trials in Grosshansdorf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Grosshansdorf at a glance
69
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

69 trials in Grosshansdorf

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mrna-4157
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VISUGROMAB
  • Sponsor:CatalYm GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Cisplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Grosshansdorf

What the registry says about research in the country

01 Lung Cancer Research

Extensive research focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel combination therapies and immunotherapy approaches. Studies are investigating treatments for both early-stage and metastatic disease.

  • Advanced therapeutic combinations
  • Immunotherapy innovations
  • Post-surgical treatments

Multiple trials exploring targeted therapies and their impact on patient survival rates.

02 Respiratory Conditions

Clinical investigations into chronic obstructive pulmonary disease (COPD) and asthma, testing new therapeutic approaches and combination treatments to improve patient outcomes.

  • Bronchodilator therapies
  • Novel treatment combinations
  • Disease management strategies

Research focuses on reducing exacerbations and improving quality of life for patients.

03 Specialized Cancer Studies

Innovative research targeting pleural mesothelioma and neuroendocrine tumors, evaluating cutting-edge treatments and therapeutic combinations.

  • Targeted molecular therapies
  • Combination treatment approaches
  • Novel drug development

Studies aim to improve survival rates and treatment efficacy in rare and aggressive cancers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.